Navigation Links
InterMune Reports Fourth Quarter and Full Year 2008 Financial Results and Business Highlights
Date:2/26/2009

8 18,272 13,272 Total revenue, net 7,401 9,627 48,152 66,692 Costs and expenses: Cost of goods sold 1,713 2,058 8,989 14,109 Research and development 26,274 25,106 104,581 105,939 General and administrative 7,795 6,611 30,260 29,577 Acquired research and development milestone - 6,225 - 13,725 Restructuring charges - - - 10,246 Total costs and expenses 35,782 40,000 143,830 173,596 Loss from operations (28,381) (30,373) (95,678) (106,904) Interest income 972 2,945 5,616 10,699 Interest expense (1,534) (696) (5,635) (2,881) Other income (expense) (3,431) (111) (2,145) 2,215 Loss from continuing operations before income taxes (32,374) (28,235) (97,842) (96,871) Income tax expense/(benefit) - (2,275) - (2,275) Loss from continuing operations (32,374) (25,960) (97,842) (94,596) Discontinued operations: Income (loss) from discontinued operations 32 79 103 4,994 Net loss $(32,342) $(25,881) $(97,739) $(89,602) Basic and diluted loss per share: Continuing operations $(0.83) $(0.67) $(2.51) $(2.67) Discontinued operations - - - 0.15 Net loss per share $(0.83) $(0.67) $(2.51) $(2.52) Shares used in computing basic and diluted net loss per share 39,062 38,753 38,982 35,493 InterMune, Inc. PRELIMINARY CONDENSED CONSOLIDATED BALANCE SHEETS (unaudite
'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. InterMune to Release Fourth Quarter, Full Year 2008 Financial Results on February 26
2. InterMune Announces Issuance of U.S. Patent for ITMN-191
3. InterMune Announces Pricing of Public Offering of 3,500,000 Shares of Common Stock
4. InterMune Reports Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF
5. InterMune to Present at J.P. Morgan Healthcare Conference
6. InterMune to Present at Deutsche Bank Biotech Boston Confab
7. InterMune Reports Third Quarter 2008 Financial Results and Business Highlights
8. InterMune to Release Third Quarter 2008 Financial Results on November 6
9. InterMune Reports Japanese Regulatory Approval of Pirfenidone in IPF
10. InterMune to Present Four Abstracts on HCV Protease Inhibitor ITMN-191 at the AASLD Meeting
11. InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/25/2015)... 2015 An increase of awareness related ... forms of food nutrients, regulatory changes and concerns related ... in demand for natural astaxanthin over the past few ... up their capacities to satisfy the rising demand. ... source astaxanthin (used in nutraceuticals, aqua feed, food and ...
(Date:3/25/2015)... Having added two International locations in Brisbane ... ITRA Global proudly announced recently the organization’s expansion into ... based in the United States, is one of the ... commercial real estate. , Saltwood International is ... exclusively advises occupiers of office space, ensuring that its ...
(Date:3/25/2015)... ATLANTA , March 25, 2015  The Technology ... state,s leading association dedicated to the promotion and economic ... today announced Streamline Health as one of its Top ... . TAG will recognize this prestigious group at the ... at the Cobb Galleria Centre. TAG,S Top ...
(Date:3/25/2015)... 25, 2015 FDNA®, the pioneer ... of Face2Gene, allowing geneticists around the globe ... well as mobile devices. Face2Gene® facilitates detection of facial ... present comprehensive and up-to-date genetic references. The date of ... ACMG 2015, in Salt Lake City, UT ...
Breaking Biology Technology:Global Astaxanthin Market to Reach Value of USD 1.1 billion by 2020, Expects Industry Experts in New Report Available at MarketPublishers.com 2International Organization Expands its Global Reach to Warsaw, Poland 2Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 2Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 3Streamline Health, Inc. Named a TAG Top 40 Innovative Technology Company 4FDNA Releases a Multi-Platform Version of Face2Gene, a Genetic Search and Reference Solution at ACMG 2015 2
... Aug. 7 SGX Pharmaceuticals,(Nasdaq: SGXP ) today announced ... 30, 2008. For the three months ended June 30, 2008, ... of $7.2 million. For,the six months ended June 30, 2008, ... The revenue in the six month period includes $10.8,million of ...
... SOUTH SAN FRANCISCO, Calif., Aug. 7 Anesiva,Inc. (Nasdaq: ... the second quarter and six months ended June 30, ... advance for Anesiva as we,introduced Zingo(TM) in the U.S. ... executive officer. "In addition, I,m pleased,to report that our ...
... Chromos Molecular,Systems Inc. ("Chromos" or the "Company") announced ... (the "Arrangement Agreement") dated,August 6, 2008 with, among ... Chromos, and Modatech Systems Inc. ("Modatech"),pursuant to which ... effect a plan,of arrangement (the "Arrangement") under section ...
Cached Biology Technology:SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 2SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 3SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 4SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 5SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 6SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 7SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 8SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008 9Anesiva Announces Second Quarter 2008 Financial Results and Update 2Anesiva Announces Second Quarter 2008 Financial Results and Update 3Anesiva Announces Second Quarter 2008 Financial Results and Update 4Anesiva Announces Second Quarter 2008 Financial Results and Update 5Anesiva Announces Second Quarter 2008 Financial Results and Update 6Anesiva Announces Second Quarter 2008 Financial Results and Update 7Anesiva Announces Second Quarter 2008 Financial Results and Update 8Chromos enters into an Arrangement Agreement 2Chromos enters into an Arrangement Agreement 3
(Date:3/12/2015)... FAIRFAX, Va. , March 12, 2015 ... company and a member of the Texas Instruments Design ... Chandrababu Naidu has demonstrated its IriShield USB MK2120U ... iris scanning facility for pension distribution. ... and assembled to be marketed in India ...
(Date:3/12/2015)... , March 12, 2015 ... standardized identity and access management (IAM) solution for ... schedule. With Beta System,s new IAM package, customers ... practices gleaned from multiple IAM implementations across different ... software as well as any necessary services and ...
(Date:3/11/2015)... DUBLIN , Mar. 11, 2015 Research and ... addition of the "Access Control Market by Product, ... to 2020" report to their offering. , ... is expected to reach $10.4 billion by 2020, with ... control market report covers the products types such as ...
Breaking Biology News(10 mins):Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2Global Access Control (Cards & Readers, Biometrics, Controllers, Management Software) Market 2015-2020 - Analysis of the $10 Billion Market 2
... as a triumph for the preservation of nature, yet the ... largest protected areas encompass vast amounts of wilderness but do ... include unusually large numbers of birds, amphibians, or mammals, according ... BioScience . The study, by Lisette Cant-Salazar and Kevin J. ...
... Chandra Tucker shines a blue light on yeast and mammalian ... start to glow. The effect is the result of a light-activated ... Researchers could use this novel "on-off switch" to control cell ... directly to diseased cells, said Tucker, an assistant research professor in ...
... Scientists from the UK and Australia have seen the ... in action for the first time. The UK team, funded ... the Wellcome Trust, is based at Birkbeck College where ... perforin uses to punch holes in rogue cells. The research ...
Cached Biology News:Researchers could use plant's light switch to control cells 2Immune system assassin's tricks visualised for the first time 2
... Combination inline heater plus multi-channel focal ... drug wash-out with a high-flow bath line ... solutions through the Perfusion Pencil.® Steady 37°C ... the bath line and tip. ...
Mouse monoclonal [ICRF 44] to Integrin alpha M...
Mouse Amphiregulin MAb (Clone 206220)...
Request Info...
Biology Products: